T313M polymorphism of the PINK1 gene in Parkinson's disease

被引:2
|
作者
Luo, Qin [1 ]
Yang, Xinling [1 ]
Yao, Yani [1 ]
Li, Hongjuan [2 ]
Wang, Yuling [1 ]
机构
[1] Xinjiang Med Univ, Affiliated Hosp 1, Dept VIP Integrated Med, Urumqi 830054, Xinjiang, Peoples R China
[2] Peoples Hosp Wenling, Dept Rehabil, Wenling 317500, Zhejiang, Peoples R China
关键词
Uygur nationality; Han nationality; Parkinson's disease; PINK1; gene; polymorphism; EARLY-ONSET PARKINSONISM; MUTATION ANALYSIS; BRAZILIAN PATIENTS; ITALIAN PATIENTS; IN-VIVO; DJ-1; PHENOTYPES; COHORT; PARK2; SNCA;
D O I
10.3892/etm.2014.1702
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study aimed to investigate the association between T313M polymorphism at exon 4 of the PTEN-induced putative kinase 1 (PINK1) gene and Parkinson's disease (PD) in the Uygur and Han populations of Xinjiang, China. Genetic DNA was extracted from 364 patients with PD from the Uygur and Han populations, as well as 346 normal control patients. Four exons of the PINK1 gene were amplified using quantitative polymerase chain reaction. The exons were then digested for restriction fragment length polymorphism analysis. Gene types and allele frequencies were identified using agarose gel electrophoresis followed by DNA sequencing to analyze the T313M polymorphisms. In the Han population, T313M polymorphism allele frequency was observed to be significantly different between the PD group and the control group (chi(2)=6.247; P<0.05). Significant differences were observed in in the T313M allele and genotype frequencies between the Uygur and Han populations (chi(2)=5.475 and chi(2)=10.950, respectively; P<0.05). Polymorphisms in the PINK1 T313M mutation may be associated with genetic susceptibility to PD.
引用
收藏
页码:286 / 290
页数:5
相关论文
共 50 条
  • [31] Increased cysteine metabolism in PINK1 models of Parkinson's disease
    Travaglio, Marco
    Michopoulos, Filippos
    Yu, Yizhou
    Popovic, Rebeka
    Foster, Edmund
    Coen, Muireann
    Martins, L. Miguel
    DISEASE MODELS & MECHANISMS, 2023, 16 (01)
  • [32] Parkinson's Disease: Are PINK1 Activators Inching Closer to the Clinic?
    Mehellou, Youcef
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (07): : 870 - 874
  • [33] The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson's Disease
    Pickrell, Alicia M.
    Youle, Richard J.
    NEURON, 2015, 85 (02) : 257 - 273
  • [34] Mechanisms of neurodegeneration in Parkinson's disease: keep neurons in the PINK1
    Brunelli, Francesco
    Valente, Enza Maria
    Arena, Giuseppe
    MECHANISMS OF AGEING AND DEVELOPMENT, 2020, 189
  • [35] PARKINSON'S DISEASE: PINK1 AND MITOCHONDRIAL COMPLEX I FUNCTION
    Morais, V. A.
    Craessaerts, K.
    Aerts, L.
    Snellinx, A.
    Verstreken, P.
    De Strooper, B.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 20 - 21
  • [36] Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
    Gandhi, Sonia
    Vaarmann, Annika
    Yao, Zhi
    Duchen, Michael R.
    Wood, Nicholas W.
    Abramov, Andrey Y.
    PLOS ONE, 2012, 7 (05):
  • [37] A common A340T variant in PINK1 gene associated with late-onset Parkinson's disease in Chinese
    Wang, Feng
    Feng, Xiuli
    Ma, Jinhong
    Zou, Haiqiang
    Chan, Piu
    NEUROSCIENCE LETTERS, 2006, 410 (02) : 121 - 125
  • [38] Identification of PINK1 (PARK6), the first mitochondrial gene causing Parkinson's disease
    Wood, N
    Muqit, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08): : 1220 - 1220
  • [39] Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
    Abramov, Andrey Yurevich
    Gegg, Matthew
    Grunewald, Anne
    Wood, Nicholas William
    Klein, Christine
    Schapira, Anthony Henry Vernon
    PLOS ONE, 2011, 6 (10):
  • [40] Clinicogenetic study of PINK1 mutations in Parkinson disease
    Li, Y.
    Kumazawa, R.
    Tomiyama, H.
    Imamichi, Y.
    Funayama, M.
    Yoshino, H.
    Sato, K.
    Takahashi, H.
    Yoshii, F.
    Hattori, N.
    Mizuno, Y.
    MOVEMENT DISORDERS, 2006, 21 : S414 - S414